Core Points - The document outlines the working rules for the independent directors' special meetings of China Film Industry Group Co., Ltd, aiming to enhance the governance structure and regulate the behavior of independent directors [1][2] - The special meetings are exclusively attended by independent directors, allowing for independent discussions and opinions on various matters [2][3] Group 1 - The company must hold at least one special meeting annually, which can be conducted in various formats, including in-person and remote [3] - Independent directors are required to attend the meetings personally or via communication methods, with provisions for delegation if necessary [4] - Certain matters, such as related party transactions and changes in commitments, must be reviewed and approved by the special meeting before being submitted to the board [6][7] Group 2 - Special meetings have the authority to independently hire intermediary institutions for audits or consultations [7] - The voting process in special meetings is one vote per director, and opinions must be clearly stated, including agreements, reservations, or objections [9] - Meeting records must be accurate and preserved for at least ten years, with confidentiality obligations imposed on all participants [10][11]

Core Points - The document outlines the management measures for specific personnel holding shares in China Film Industry Group Co., Ltd, emphasizing compliance with relevant laws and regulations [1][2][3] Group 1: General Provisions - The purpose of the measures is to strengthen the management of shareholding and changes for specific personnel in the company [1] - Specific personnel include directors, senior management, and other individuals who can access insider information [1] Group 2: Restrictions on Trading - Specific personnel must be aware of legal regulations and fulfill notification and reporting obligations before trading company stocks [2] - Trading restrictions apply from the moment insider information is known until it is publicly disclosed [2][3] - Directors and senior management are prohibited from trading company stocks during specific periods, such as 15 days before annual and semi-annual report announcements [2][3] Group 3: Transfer Limitations - Directors and senior management cannot transfer shares within one year of the company's stock listing or within six months after leaving the company [3][4] - Short-term trading is prohibited, defined as buying and selling shares within six months [4] Group 4: Reporting and Disclosure - The board of directors is responsible for establishing and supervising the management system for shareholding changes [7] - Specific personnel must report their shareholding information within two trading days of any changes [7][8] - Any planned share reductions must be reported 15 trading days in advance, detailing the number of shares and reasons for the reduction [8] Group 5: Legal Responsibilities - Specific personnel who violate these measures may be liable for damages caused to the company and must compensate for reasonable expenses incurred [11] - Violations that result in losses to shareholders or investors may lead to administrative, civil, or criminal liabilities [11]

中国电影产业集团股份有限公司 重大信息内部报告制度 （2025 年 6 月，经公司第三届董事会第二十次会议审议通过） 第一章 总 则 第一条 为加强中国电影产业集团股份有限公司（简称"公司" 的重大信息内部报告工作，确保公司规范履行信息披露义务，根据《中 华人民共和国证券法》《上海证券交易所股票上市规则》 （简称"《上 市规则》"） 《上海证券交易所上市公司自律监管指引》等法律法规、 规范性文件以及《中国电影产业集团股份有限公司章程》 （简称" 《公 司章程》" ）《中国电影产业集团股份有限公司信息披露管理制度》 称"《信披制度》 "）的规定，结合公司实际情况，制订本制度。 第二条 本制度适用于公司及纳入公司合并报表范围的全资、控 股子公司（简称"子公司"） 第三条 本制度所称"重大信息内部报告"是指，当出现、发生 或者即将发生可能对公司股票及其衍生品种的交易价格产生较大影 响的情形或者事件时，负有报告义务的责任人应当及时履行内部报告 程序。 第四条 本制度所称"及时"是指自获悉该事项或筹划事项形成 意向或方案的 2 日内。 第五条 本制度所称"报告义务人"包括： （一）公司董事和高级管理人员； （二）公司各 ...

Core Viewpoint - The document outlines the management system for the deferral and exemption of information disclosure by China Film Industry Group Co., Ltd, ensuring compliance with relevant regulations and protecting sensitive information [1][2][3]. Group 1: General Principles - The company aims to standardize the deferral and exemption of information disclosure to comply with laws and regulations [1]. - Information disclosure must be truthful, accurate, complete, timely, and fair, avoiding misuse of deferral or exemption to mislead investors [1][2]. Group 2: Applicable Situations for Deferral and Exemption - Information can be deferred or exempted if it involves state secrets or could violate confidentiality regulations [1][2]. - Business secrets can be deferred or exempted if disclosure could lead to unfair competition or harm the interests of the company or others [2][3]. Group 3: Approval and Registration Procedures - The board of directors oversees the deferral and exemption process, with the board secretary responsible for coordination [3][4]. - Specific internal approval procedures must be followed for deferring or exempting information disclosure [4][5]. Group 4: Subsequent Management of Deferred and Exempted Information - The company must report deferred or exempted information to regulatory bodies within ten days after the announcement of periodic reports [5][6]. - If the reasons for deferral or exemption are eliminated, or if information leaks occur, the company must disclose the information promptly [6]. Group 5: Accountability - Violations of the established procedures may lead to accountability measures against responsible personnel [6][7].

Core Insights - "Ne Zha" has achieved a remarkable box office performance, grossing 15.445 billion in the domestic market and ranking fifth in global box office history [1][6] - The film has broken 113 records, including being the highest-grossing animated film globally and the first Asian film to surpass 10 billion [6][7] - The success of "Ne Zha" signifies a transformation in Chinese animation, showcasing its potential to create globally resonant original IPs [6][8] Industry Impact - The film's release has led to an estimated 40% increase in investment in domestic animation, reflecting heightened confidence in the sector [8] - The surrounding merchandise sales have also surged, with total sales of derivative products exceeding 100 billion, indicating a thriving industry ecosystem [8] - "Ne Zha" represents a shift in the Chinese animation industry from merely catching up technologically to establishing a cultural benchmark with global influence [8][9] Cultural Significance - The film resonates with universal themes of breaking prejudice and defying fate, which has allowed it to connect with audiences worldwide [6][7] - It has been praised by international critics for its stunning visual effects and storytelling, demonstrating that Chinese cinema can effectively convey its narratives without relying on Western frameworks [7] - The success of "Ne Zha" is seen as a beacon for future original IPs, paving the way for more Chinese stories to reach global audiences [9]

Group 1 - Taotao Automotive expects a net profit of 310 million to 360 million yuan for the first half of 2025, representing a year-on-year increase of 70.34% to 97.81% [1] - The company specializes in the research, production, and sales of all-terrain vehicles, electric golf carts, electric scooters, electric balance bikes, electric bicycles, and their accessories [1] - China Communications Construction Company plans to repurchase shares worth between 500 million to 1 billion yuan, with a maximum repurchase price of 13.58 yuan per share [1][2] Group 2 - Annoqi's subsidiary received a government subsidy of 1.65 million yuan, accounting for 34.77% of the company's latest audited net profit [2] - Annoqi focuses on the research, production, and sales of mid-to-high-end differentiated dyes [3] - Minfeng Special Paper announced the complete shutdown of its Nanhu plant, as its Haiyan plant is now capable of handling the production capacity [4] Group 3 - Aoto Electronics received a trademark registration certificate from Saudi Arabia, covering various electronic products [5] - Landi Group plans to acquire up to 20.1667% of the shares of Jujia Technology for a total price not exceeding 121 million yuan [6][7] - Lifan Pharmaceutical's Danpi phenol raw material drug has been approved for market launch, utilizing a new process that enhances efficiency and meets market demand [8] Group 4 - Shanghai Construction received a total of 548 million yuan in government subsidies, which accounts for 22.79% of the company's latest audited net profit [8] - Wanbangde's subsidiary received ethical approval for a key clinical trial of a new drug for Alzheimer's disease [8] - Prolo Pharmaceutical's subsidiary received approval for the market launch of a new raw material drug for liver cancer treatment [9] Group 5 - Chenguang New Materials received a government subsidy of 26 million yuan, representing 62.86% of the company's latest audited net profit [10] - Sanyou Medical's subsidiary received a government subsidy of 331,000 yuan, accounting for 28.86% of the company's latest audited net profit [11] - Weichai Heavy Machinery expects a net profit of 132 million to 151 million yuan for the first half of 2025, reflecting a year-on-year increase of 40% to 60% [12] Group 6 - Guanhao Biological announced the termination of its application for a specific stock issuance [13] - China Film plans to use up to 1.5 billion yuan of idle funds for cash management [14] - Aotai Biological intends to use up to 480 million yuan of idle raised funds for cash management [15] Group 7 - Helin Micro-Nano is planning to issue overseas shares and list on the Hong Kong Stock Exchange [17] - Jinpan Technology's vice president resigned due to personal health reasons [18] - Tongyi Zhong's chairman and general manager plan to reduce their shareholdings in the company [19] Group 8 - Naipu Mining signed an overseas contract worth 18.85 million USD [21] - Zhengye Technology completed an asset sale transaction worth 178 million yuan [23] - Lianxin Equipment won a bid for a project worth 157 million yuan from BOE [24] Group 9 - Smart Control plans to apply for a comprehensive credit line of up to 260 million yuan from banks [25] - Keyuan Pharmaceutical's application for issuing shares to purchase assets has been accepted by the Shenzhen Stock Exchange [27] - Meige Intelligent's H-share listing application materials have been received by the China Securities Regulatory Commission [29] Group 10 - Siwei Tuxin's subsidiary submitted an H-share listing application [32] - Metro Design's application for issuing shares to purchase assets has been accepted by the Shenzhen Stock Exchange [32] - Aeston submitted an application for H-share listing [34] Group 11 - Jiu Ri New Materials' shareholders plan to reduce their holdings by a total of 98,900 shares [34] - Yihua Tong's shareholder plans to reduce their holdings by up to 700,000 shares [35] - Xishanghai plans to distribute a cash dividend of 0.08 yuan per share [36] Group 12 - Zhejiang Natural plans to distribute a cash dividend of 1.97 yuan for every 10 shares [37] - Kouzi Jiao plans to distribute a cash dividend of 1.30 yuan per share [38] - Huitong Group plans to distribute a cash dividend of 0.023 yuan per share [40] Group 13 - Tongyong Co. plans to reduce its holdings by up to 0.31% of the company's shares [41] - China Shenhua plans to distribute a cash dividend of 2.26 yuan for every 10 shares [43] - Huangting International's executive director resigned due to personal reasons [45] Group 14 - Jinkai New Energy plans to distribute a cash dividend of 1 yuan for every 10 shares [46] - Heimu Dan plans to distribute a cash dividend of 0.041 yuan per share [47] - Feiyada plans to acquire all or part of the controlling stake in Chang Kong Gear [48]

第二条 独立董事专门会议（简称"专门会议"）是指全部由独立 董事参加的会议。专门会议对所议事项进行独立研讨，并且形成讨论 意见。 中国电影产业集团股份有限公司 独立董事专门会议工作细则 （2025 年 6 月，经公司第三届董事会第二十次会议审议通过） 第一条 为进一步完善中国电影产业集团股份有限公司（简称"公 司"）的治理结构，规范独立董事行为，充分发挥独立董事在公司治 理中的作用，根据《中华人民共和国公司法》《上市公司独立董事管 理办法》《上市公司治理准则》《上海证券交易所股票上市规则》《上 海证券交易所上市公司自律监管指引》等法律法规、规范性文件及《中 国电影产业集团股份有限公司章程》（简称"《公司章程》"）、《中国 电影产业集团股份有限公司独立董事工作制度》(简称"《独立董事工 作制度》")的有关规定，结合公司实际，制定本工作细则。 第三条 公司每年至少召开一次专门会议。会议可采取现场、通 讯、现场结合通讯等方式召开，于会议召开前 5 日发出会议通知及相 关会议资料。情况紧急，需要尽快召开会议的，可以随时通过电话或 者其他口头方式发出会议通知。 第四条 独立董事应当亲自出席会议，或以电话、网络等通讯形 ...

中国电影产业集团股份有限公司 董事会审计委员会工作细则 （2025 年 6 月，经公司第三届董事会第二十次会议审议通过） 第一章 总 则 第一条 为完善中国电影产业集团股份有限公司（简称"公司"） 的内部控制体系，健全上市公司内部监督机制，保障公司和股东的合 法权益，根据《中华人民共和国公司法》（简称"《公司法》"）《上 海证券交易所股票上市规则》（简称"《上市规则》"）《上海证券 交易所上市公司自律监管指引》等法律法规，和《中国电影产业集团 股份有限公司章程》（简称"《公司章程》"）的有关规定，公司董 事会设审计委员会（简称"审计委"），并制定本工作细则。 第二条 审计委是董事会的专门工作机构，主要负责监督及评 估公司的内外部审计工作，促进公司建立有效的内部控制并提供真实、 准确、完整的财务报告。 第三条 审计委履行职责时，公司经理层及相关部门须予以配 合。董事、高级管理人员应当如实向审计委提供有关情况和资料，不 得妨碍审计委行使职权。 审计委行使职权所必需的费用，由公司承担。 第二章 人员组成 第四条 审计委由至少 3 名不在公司担任高级管理人员的董事 组成，其中独立董事应当过半数。 审计委委员（简称"委 ...

中国电影产业集团股份有限公司 重大信息内部报告制度 （2025 年 6 月，经公司第三届董事会第二十次会议审议通过） 第一章 总 则 第一条 为加强中国电影产业集团股份有限公司（简称"公司"） 的重大信息内部报告工作，确保公司规范履行信息披露义务，根据《中 华人民共和国证券法》《上海证券交易所股票上市规则》（简称"《上 市规则》"）《上海证券交易所上市公司自律监管指引》等法律法规、 规范性文件以及《中国电影产业集团股份有限公司章程》（简称"《公 司章程》"）《中国电影产业集团股份有限公司信息披露管理制度》（简 称"《信披制度》"）的规定，结合公司实际情况，制订本制度。 第二条 本制度适用于公司及纳入公司合并报表范围的全资、控 股子公司（简称"子公司"）。 第三条 本制度所称"重大信息内部报告"是指，当出现、发生 或者即将发生可能对公司股票及其衍生品种的交易价格产生较大影 响的情形或者事件时，负有报告义务的责任人应当及时履行内部报告 程序。 第四条 本制度所称"及时"是指自获悉该事项或筹划事项形成 意向或方案的 2 日内。 第五条 本制度所称"报告义务人"包括： （一）公司董事和高级管理人员； （二）公司各部门 ...

中国电影产业集团股份有限公司 财务管理制度 （2025 年 6 月，经公司第三届董事会第二十次会议审议通过） 第一章 总 则 第一条 为加强中国电影产业集团股份有限公司(简称"公司") 财务管理，贯彻公司经营管理理念，建立健全与行业特点、愿景 文化、战略规划、发展阶段、组织架构相适应的财务管理体系， 根据《中华人民共和国公司法》《中华人民共和国会计法》《企 业会计准则》等国家有关法律法规和《中国电影产业集团股份有 限公司章程》（简称"《公司章程》"）有关规定，结合公司实 际情况和管理要求，制定本制度。 第二条 财务管理目标 （一）以支撑战略、支持决策、服务业务、创造价值、防控 风险为目标，以规范、精益、集约、稳健、高效、智慧为标准， 持续优化管理手段，不断创新管理模式，积极应用先进管理工具， 推进深化业财融合； （二）不断夯实财务报告、资金管控、税务管理等基础保障 职能，深化拓展成本管控、投融资管理、资本运作等价值创造职 能，确保财务资源科学配置、财务运作高效协同； （三）努力实现管理颗粒精细化、管理视角多维化、管理场 景动态化、管理信息实时化，确保财务管理反应敏捷、运转高效。 第三条 财务管理的基本原则 （ ...